The global digital pcr market was valued at $508.82 million in 2020, and is projected to reach $1,305.30 million by 2030, growing at a CAGR of 8.6% from 2021 to 2030.
The rapid improvements in genomic research are one of the main reasons propelling the growth of the Digital PCR (dPCR) market. Nucleic acid measurement is crucial for genomic studies and dPCR technology excels at this task. The use of dPCR by academics and medical professionals to investigate genetic variants, find uncommon mutations, and assess gene expression levels is growing. The need for dPCR is expected to rise dramatically as genomics continues to play a crucial role in personalized medicine and disease research. Clinical diagnostics has seen substantial growth in the use of digital PCR. It is crucial for determining the absolute quantity of target DNA or RNA molecules with high sensitivity and specificity, monitoring viral load, and identifying genetic abnormalities. The introduction of dPCR in clinical settings is being driven by the ongoing demand for precise and early illness detection, particularly in the context of infectious diseases and cancer.
Liquid biopsy is a revolutionary technique for identifying and monitoring cancer. Because technology makes it feasible to discover minute quantities of cancer DNA or RNA in blood samples, digital PCR is crucial for liquid biopsies. This non-invasive approach has the potential to change the treatment of cancer and significantly accelerate the growth of the dPCR industry by allowing early diagnosis, treatment monitoring, and the discovery of drug-resistant mutations. Single-cell analysis is another area where dPCR is excelling. Researchers are increasingly interested in studying individual cells in order to comprehend illness origins and show cellular heterogeneity. Additionally, the industry's ability to study single-cell gene expression and recognize unusual genomic processes is what fuels its development potential.
The demand for dPCR is increasing as medical practice shifts towards personalized care in response to the requirement for customized treatment plans. Because of its accuracy and capacity to spot certain genetic abnormalities, digital PCR is an essential tool for locating patient-specific biomarkers and directing therapeutic choices. The use of dPCR in patient classification and treatment decision-making is anticipated to increase as personalized medicine becomes more prevalent. The discovery of biologics, gene treatments, and vaccines is driving the fast growth of the biopharmaceutical business. In the development of biopharmaceuticals, digital PCR is essential for quality assurance, process monitoring, and nucleic acid quantification. The need for dPCR equipment and services increases along with the industry's continued expansion.
The digital PCR market size is segmented on the basis of technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR. Depending on product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others.
As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations.
By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).
Depending on technology, the droplet digital PCR (ddPCR) segment dominated the market in 2020, and this trend is expected to continue during the forecast period owing to rise in prevalence of infectious diseases. However, the chip based digital PCR segment is expected to witness considerable growth during the forecast period due to advancement in chip based digital PCR technology.
On the basis of product type, the digital PCR systems segment dominated the market in 2020, and this trend is expected to continue during the forecast period owing to rise in demand for molecular diagnostics in personalized medicine and new product launch. However, the consumables & reagents segment is expected to witness considerable growth during the digital PCR market forecast period due to surge in demand for early diagnosis and increase in number of key players to manufacture consumable and reagents for digital PCR.
By application, Depending on end user, the pharmaceuticals & biotechnology industries segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period owing to rise in number of cancer patients. However, the clinical diagnostic laboratories segment is expected to witness considerable growth during the forecast period due to increase in number of clinical research centers and rise in number of clinical trials.
North America is a significant market for dPCR technology, especially the United States and Canada. The area has a highly developed healthcare infrastructure, places a high priority on genomics research, and has a thriving biotechnology industry, all of which contribute to the high adoption of PCR. Bio-Rad Laboratories, Thermo Fisher Scientific, and Fluidigm are significant companies in this area. The need for dPCR in North America is being driven by clinical diagnostics, cancer research, and personalized medicine.
| Report Metric | Details |
| Report Name | Global Digital PCR Market |
| Base Year | 2020 |
| Forecasted years | 2021-2030 |
| By Company |
|
| Segment by Technology |
|
| Segment by Product Type |
|
| Segment by Application |
|
| Segment by End User |
|
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
Ans. The global digital pcr market was valued at USD 508.82 million in 2020, and is projected to reach USD 1,305.30 million by 2030, growing at a CAGR of 8.6% from 2021 to 2030.
Ans. The global digital polymerase chain reaction market is expected to grow at a compound annual growth rate of 8.6% from 2021 to 2030.
Ans. Bio-Rad Laboratories, Inc., 4basebio AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, Combinati, Inc., and Thermo Fisher Scientific, Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in prevalence of infectious diseases and cancer
3.5.1.2.Increase in awareness and acceptance of personalized medicines
3.5.1.3.Technological advancements
3.5.2.Restraints
3.5.2.1.High cost of dPCR devices
3.5.2.2.Reimbursement issues
3.5.3.Opportunity
3.5.3.1.Increase in funding for R&D activities
3.6.NGS technology Impact on Digital PCR Market
3.7.Impact analysis of COVID-19 on the digital PCR market
CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY
4.1.Overview
4.1.1.Market size and forecast
4.1.2.Market size and forecast for PCR Market, 2017-2023
4.2.Droplet digital PCR
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Chip based digital PCR
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.BEAMing dPCR
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Consumables & reagents
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Digital PCR systems
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Software & services
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Research
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Clinical diagnostics
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Forensic & others
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Clinical diagnostic laboratories
7.2.1.Market size and forecast
7.2.2.Market analysis, by country
7.3.Pharmaceuticals & biotechnology industries
7.3.1.Market size and forecast
7.3.2.Market analysis, by country
7.4.Universities & other organizations
7.4.1.Market size and forecast
7.4.2.Market analysis, by country
CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.North America digital PCR market, by country
8.2.2.1.U.S. digital PCR market, by technology
8.2.2.2.U.S. digital PCR market, by product type
8.2.2.3.U.S. digital PCR market, by application
8.2.2.4.U.S. digital PCR market, by end user
8.2.2.5.Canada digital PCR market, by technology
8.2.2.6.Canada digital PCR market, by product type
8.2.2.7.Canada digital PCR market, by application
8.2.2.8.Canada digital PCR market, by end user
8.2.2.9.Mexico digital PCR market, by technology
8.2.2.10.Mexico digital PCR market, by product type
8.2.2.11.Mexico digital PCR market, by application
8.2.2.12.Mexico digital PCR market, by end user
8.2.3.North America digital PCR market, by technology
8.2.4.North America digital PCR market, by product type
8.2.5.North America digital PCR market, by application
8.2.6.North America digital PCR market, by end user
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Europe digital PCR market, by country
8.3.2.1.Germany digital PCR market, by technology
8.3.2.2.Germany digital PCR market, by product type
8.3.2.3.Germany digital PCR market, by application
8.3.2.4.Germany digital PCR market, by end user
8.3.2.5.France digital PCR market, by technology
8.3.2.6.France digital PCR market, by product type
8.3.2.7.France digital PCR market, by application
8.3.2.8.France digital PCR market, by end user
8.3.2.9.UK digital PCR market, by technology
8.3.2.10.UK digital PCR market, by product type
8.3.2.11.UK digital PCR market, by application
8.3.2.12.UK digital PCR market, by end user
8.3.2.13.Italy digital PCR market, by technology
8.3.2.14.Italy digital PCR market, by product type
8.3.2.15.Italy digital PCR market, by application
8.3.2.16.Italy digital PCR market, by end user
8.3.2.17.Spain digital PCR market, by technology
8.3.2.18.Spain digital PCR market, by product type
8.3.2.19.Spain digital PCR market, by application
8.3.2.20.Spain digital PCR market, by end user
8.3.2.21.Rest of Europe digital PCR market, by technology
8.3.2.22.Rest of Europe digital PCR market, by product type
8.3.2.23.Rest of Europe digital PCR market, by application
8.3.2.24.Rest of Europe digital PCR market, by end user
8.3.3.Europe digital PCR market, by technology
8.3.4.Europe digital PCR market, by product type
8.3.5.Europe digital PCR market, by application
8.3.6.Europe digital PCR market, by end user
8.4.Asia-Pacific
8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific digital PCR market, by country
8.4.2.1.Japan digital PCR market, by technology
8.4.2.2.Japan digital PCR market, by product type
8.4.2.3.Japan digital PCR market, by application
8.4.2.4.Japan digital PCR market, by end user
8.4.2.5.China digital PCR market, by technology
8.4.2.6.China digital PCR market, by product type
8.4.2.7.China digital PCR market, by application
8.4.2.8.China digital PCR market, by end user
8.4.2.9.Australia digital PCR market, by technology
8.4.2.10.Australia digital PCR market, by product type
8.4.2.11.Australia digital PCR market, by application
8.4.2.12.Australia digital PCR market, by end user
8.4.2.13.India digital PCR market, by technology
8.4.2.14.India digital PCR market, by product type
8.4.2.15.India digital PCR market, by application
8.4.2.16.India digital PCR market, by end user
8.4.2.17.South Korea digital PCR market, by technology
8.4.2.18.South Korea digital PCR market, by product type
8.4.2.19.South Korea digital PCR market, by application
8.4.2.20.South Korea digital PCR market, by end user
8.4.2.21.Taiwan digital PCR market, by technology
8.4.2.22.Taiwan digital PCR market, by product type
8.4.2.23.Taiwan digital PCR market, by application
8.4.2.24.Taiwan digital PCR market, by end user
8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user
8.4.3.Asia-Pacific digital PCR market, by technology
8.4.4.Asia-Pacific digital PCR market, by product type
8.4.5.Asia-Pacific digital PCR market, by application
8.4.6.Asia-Pacific digital PCR market, by end user
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.LAMEA digital PCR market, by country
8.5.2.1.Brazil digital PCR market, by technology
8.5.2.2.Brazil digital PCR market, by product type
8.5.2.3.Brazil digital PCR market, by application
8.5.2.4.Brazil digital PCR market, by end user
8.5.2.5.Saudi Arabia digital PCR market, by technology
8.5.2.6.Saudi Arabia digital PCR market, by product type
8.5.2.7.Saudi Arabia digital PCR market, by application
8.5.2.8.Saudi Arabia digital PCR market, by end user
8.5.2.9.South Africa digital PCR market, by technology
8.5.2.10.South Africa digital PCR market, by product type
8.5.2.11.South Africa digital PCR market, by application
8.5.2.12.South Africa digital PCR market, by end user
8.5.2.13.Rest of LAMEA digital PCR market, by technology
8.5.2.14.Rest of LAMEA digital PCR market, by product type
8.5.2.15.Rest of LAMEA digital PCR market, by application
8.5.2.16.Rest of LAMEA digital PCR market, by end user
8.5.3.LAMEA digital PCR market, by technology
8.5.4.LAMEA digital PCR market, by product type
8.5.5.LAMEA digital PCR market, by application
8.5.6.LAMEA digital PCR market, by end user
CHAPTER 9:COMPANY PROFILES
9.1.Avance Biosciences
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business Performance
9.2.BIO-RAD LABORATORIES, INC.
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.COMBINATI, INC.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments
9.4.FLUIDIGM CORPORATION
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.JN MEDSYS
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments
9.6.MERCK KGAA
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.QIAGEN N.V.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segment
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.SYSMEX CORPORATION
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.STILLA TECHNOLOGIES
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments
9.10.THERMO FISHER SCIENTIFIC, INC.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
LIST OF TABLES
TABLE 1. GLOBAL DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 2. DIGITAL PCR MARKET REVENUE, FOR DROPLET DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 3. DIGITAL PCR MARKET DROPLET DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. DIGITAL PCR MARKET REVENUE, FOR CHIP BASED DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 5. DIGITAL PCR MARKET CHIP BASED DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. DIGITAL PCR MARKET REVENUE, FOR BEAMING DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
TABLE 7. DIGITAL PCR MARKET BEAMING DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 9. DIGITAL PCR MARKET REVENUE, FOR DIGITAL PCR SYSTEMS, BY REGION , 2020-2030,($MILLION)
TABLE 10. DIGITAL PCR MARKET DIGITAL PCR SYSTEMS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. DIGITAL PCR MARKET REVENUE, FOR CONSUMABLES AND REAGENTS, BY REGION , 2020-2030,($MILLION)
TABLE 12. DIGITAL PCR MARKET CONSUMABLES AND REAGENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. DIGITAL PCR MARKET REVENUE, FOR SOFTWARE AND SERVICES, BY REGION , 2020-2030,($MILLION)
TABLE 14. DIGITAL PCR MARKET SOFTWARE AND SERVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. GLOBAL DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 16. DIGITAL PCR MARKET REVENUE, FOR RESEARCH, BY REGION , 2020-2030,($MILLION)
TABLE 17. DIGITAL PCR MARKET RESEARCH BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. DIGITAL PCR MARKET REVENUE, FOR CLINICAL DIAGNOSTICS, BY REGION , 2020-2030,($MILLION)
TABLE 19. DIGITAL PCR MARKET CLINICAL DIAGNOSTICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. DIGITAL PCR MARKET REVENUE, FOR FORENSIC AND OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 21. DIGITAL PCR MARKET FORENSIC AND OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. GLOBAL DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 23. DIGITAL PCR MARKET REVENUE, FOR PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRIES, BY REGION , 2020-2030,($MILLION)
TABLE 24. DIGITAL PCR MARKET PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. DIGITAL PCR MARKET REVENUE, FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION , 2020-2030,($MILLION)
TABLE 26. DIGITAL PCR MARKET CLINICAL DIAGNOSTIC LABORATORIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. DIGITAL PCR MARKET REVENUE, FOR UNIVERSITIES AND OTHER ORGANIZATIONS, BY REGION , 2020-2030,($MILLION)
TABLE 28. DIGITAL PCR MARKET UNIVERSITIES AND OTHER ORGANIZATIONS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. DIGITAL PCR MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 30. ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 31. ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 32. ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 33. ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 34. ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 35. JAPAN DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 36. JAPAN DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 37. JAPAN DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 38. JAPAN DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 39. CHINA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 40. CHINA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 41. CHINA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 42. CHINA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. AUSTRALIA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 44. AUSTRALIA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 45. AUSTRALIA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 46. AUSTRALIA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. INDIA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 48. INDIA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 49. INDIA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 50. INDIA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. SOUTH KOREA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 52. SOUTH KOREA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 53. SOUTH KOREA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 54. SOUTH KOREA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 56. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 57. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 58. TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 59. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 60. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 61. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 62. REST OF ASIA-PACIFIC DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 63. LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 64. LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 65. LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 66. LAMEA DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 67. LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 68. BRAZIL DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 69. BRAZIL DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 70. BRAZIL DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 71. BRAZIL DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 72. SAUDI ARABIA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 73. SAUDI ARABIA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 74. SAUDI ARABIA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 75. SAUDI ARABIA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 76. SOUTH AFRICA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 77. SOUTH AFRICA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 78. SOUTH AFRICA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 79. SOUTH AFRICA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. REST OF LAMEA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 81. REST OF LAMEA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 82. REST OF LAMEA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 83. REST OF LAMEA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 84. NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 85. NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 86. NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 87. NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 88. NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 89. U.S. DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 90. U.S. DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 91. U.S. DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 92. U.S. DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 93. CANADA DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 94. CANADA DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 95. CANADA DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 96. CANADA DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 97. MEXICO DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 98. MEXICO DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 99. MEXICO DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 100. MEXICO DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 101. EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 102. EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 103. EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 104. EUROPE DIGITAL PCR MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 105. EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 106. GERMANY DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 107. GERMANY DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 108. GERMANY DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 109. GERMANY DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 110. FRANCE DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 111. FRANCE DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 112. FRANCE DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 113. FRANCE DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 114. UNITED KINGDOM DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 115. UNITED KINGDOM DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 116. UNITED KINGDOM DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 117. UNITED KINGDOM DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 118. ITALY DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 119. ITALY DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 120. ITALY DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 121. ITALY DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 122. SPAIN DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 123. SPAIN DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 124. SPAIN DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 125. SPAIN DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 126. REST OF EUROPE DIGITAL PCR MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 127. REST OF EUROPE DIGITAL PCR MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 128. REST OF EUROPE DIGITAL PCR MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 129. REST OF EUROPE DIGITAL PCR MARKET BY END USER 2020-2030,($MILLION)
TABLE 130.AVANCE BIOSCIENCES: COMPANY SNAPSHOT
TABLE 131.AVANCE BIOSCIENCES: OPERATING SEGMENTS
TABLE 132.AVANCE BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 133.AVANCE BIOSCIENCES: NET SALES,
TABLE 134.AVANCE BIOSCIENCES: KEY STRATERGIES
TABLE 135.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 136.BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 137.BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 138.BIO-RAD LABORATORIES, INC.: NET SALES,
TABLE 139.BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
TABLE 140.FLUIDIGM CORPORATION: COMPANY SNAPSHOT
TABLE 141.FLUIDIGM CORPORATION: OPERATING SEGMENTS
TABLE 142.FLUIDIGM CORPORATION: PRODUCT PORTFOLIO
TABLE 143.FLUIDIGM CORPORATION: NET SALES,
TABLE 144.FLUIDIGM CORPORATION: KEY STRATERGIES
TABLE 145.JN MEDSYS: COMPANY SNAPSHOT
TABLE 146.JN MEDSYS: OPERATING SEGMENTS
TABLE 147.JN MEDSYS: PRODUCT PORTFOLIO
TABLE 148.JN MEDSYS: NET SALES,
TABLE 149.JN MEDSYS: KEY STRATERGIES
TABLE 150.MERCK KGAA: COMPANY SNAPSHOT
TABLE 151.MERCK KGAA: OPERATING SEGMENTS
TABLE 152.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 153.MERCK KGAA: NET SALES,
TABLE 154.MERCK KGAA: KEY STRATERGIES
TABLE 155.PRECIGENOME LLC: COMPANY SNAPSHOT
TABLE 156.PRECIGENOME LLC: OPERATING SEGMENTS
TABLE 157.PRECIGENOME LLC: PRODUCT PORTFOLIO
TABLE 158.PRECIGENOME LLC: NET SALES,
TABLE 159.PRECIGENOME LLC: KEY STRATERGIES
TABLE 160.QIAGEN N.V: COMPANY SNAPSHOT
TABLE 161.QIAGEN N.V: OPERATING SEGMENTS
TABLE 162.QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 163.QIAGEN N.V: NET SALES,
TABLE 164.QIAGEN N.V: KEY STRATERGIES
TABLE 165.STILLA TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 166.STILLA TECHNOLOGIES: OPERATING SEGMENTS
TABLE 167.STILLA TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 168.STILLA TECHNOLOGIES: NET SALES,
TABLE 169.STILLA TECHNOLOGIES: KEY STRATERGIES
TABLE 170.SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 171.SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 172.SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 173.SYSMEX CORPORATION: NET SALES,
TABLE 174.SYSMEX CORPORATION: KEY STRATERGIES
TABLE 175.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 176.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 177.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 178.THERMO FISHER SCIENTIFIC, INC.: NET SALES,
TABLE 179.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.DIGITAL PCR MARKET SEGMENTATION
FIGURE 2.DIGITAL PCR MARKET,2020-2030
FIGURE 3.DIGITAL PCR MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.DIGITAL PCR MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.DIGITAL PCR MARKET,BY TECHNOLOGY,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DROPLET DIGITAL PCR DIGITAL PCR MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CHIP BASED DIGITAL PCR DIGITAL PCR MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BEAMING DIGITAL PCR DIGITAL PCR MARKET,2020-2030(%)
FIGURE 15.DIGITAL PCR MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL PCR SYSTEMS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES AND REAGENTS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SOFTWARE AND SERVICES DIGITAL PCR MARKET,2020-2030(%)
FIGURE 19.DIGITAL PCR MARKET,BY APPLICATION,2020(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF RESEARCH DIGITAL PCR MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF CLINICAL DIAGNOSTICS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF FORENSIC AND OTHERS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 23.DIGITAL PCR MARKET,BY END USER,2020(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRIES DIGITAL PCR MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CLINICAL DIAGNOSTIC LABORATORIES DIGITAL PCR MARKET,2020-2030(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF UNIVERSITIES AND OTHER ORGANIZATIONS DIGITAL PCR MARKET,2020-2030(%)
FIGURE 27.DIGITAL PCR MARKET BY REGION,2020
FIGURE 28.JAPAN DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 29.CHINA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 30.AUSTRALIA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 31.INDIA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH KOREA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 33.TAIWAN, REPUBLIC OF CHINA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 35.BRAZIL DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 36.SAUDI ARABIA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 37.SOUTH AFRICA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 38.REST OF LAMEA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 39.U.S. DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 40.CANADA DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 41.MEXICO DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 42.GERMANY DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 43.FRANCE DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 44.UNITED KINGDOM DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 45.ITALY DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 46.SPAIN DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 47.REST OF EUROPE DIGITAL PCR MARKET,2020-2030($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52.COMPETITIVE DASHBOARD
FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 54.AVANCE BIOSCIENCES.: NET SALES ,($MILLION)
FIGURE 55.BIO-RAD LABORATORIES, INC..: NET SALES ,($MILLION)
FIGURE 56.FLUIDIGM CORPORATION.: NET SALES ,($MILLION)
FIGURE 57.JN MEDSYS.: NET SALES ,($MILLION)
FIGURE 58.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 59.PRECIGENOME LLC.: NET SALES ,($MILLION)
FIGURE 60.QIAGEN N.V.: NET SALES ,($MILLION)
FIGURE 61.STILLA TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 62.SYSMEX CORPORATION.: NET SALES ,($MILLION)
FIGURE 63.THERMO FISHER SCIENTIFIC, INC..: NET SALES ,($MILLION)
$5769
$6929
$10663
HAVE A QUERY?
OUR CUSTOMER
SIMILAR REPORTS
Add to Cart
Add to Cart
Add to Cart
Add to Cart